VAERS reports by lot

GSK DTaP/Tdap lot 7C9NJ: VAERS reports

42 VAERS reports list lot 7C9NJ as a GSK DTaP/Tdap vaccine, received between 2023-04-28 and 2024-12-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
42
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2364%
Dermatological (non-injection-site)411%
Allergic / Anaphylactic38%
Gastrointestinal26%
General / Systemic (non-local)26%
Musculoskeletal13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
Michigan3
Virginia3
North Carolina2
Tennessee2
California2
Vermont2
Alabama2
New Hampshire1
Florida1
Massachusetts1
Nevada1

Reports by month received

2023-041
2023-064
2023-073
2023-086
2023-093
2023-103
2023-113
2024-022
2024-031
2024-043
2024-055
2024-071
2024-081
2024-101
2024-111
2024-124

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.